H-Gly-Cys(1)-Cys(2)-DL-Dap-His-Pro-Ala-Cys(1)-Ser-Val-Asn-Asn-Pro-Asp-Ile-Cys(2)-NH2

InChIKey	`XTMVSVQIYRTKIW-PVJUYUROSA-N`
Compound Name	H-Gly-Cys(1)-Cys(2)-DL-Dap-His-Pro-Ala-Cys(1)-Ser-Val-Asn-Asn-Pro-Asp-Ile-Cys(2)-NH2
Canonical SMILES	`CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@@H](C(N)=O)NC1=O)C(=O)NC(CN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Homologous
Avg pChEMBL	7.75
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q9GZZ6	CHRNA10	Homo sapiens	Human	PF02931 PF02932	8.4	IC50	ChEMBL
Q9UGM1	CHRNA9	Homo sapiens	Human	PF02931 PF02932	8.4	IC50	ChEMBL
P17787	CHRNB2	Homo sapiens	Human	PF02931 PF02932	7.7	IC50	ChEMBL
P32297	CHRNA3	Homo sapiens	Human	PF02931 PF02932	7.7	IC50	ChEMBL
P36544	CHRNA7	Homo sapiens	Human	PF02931 PF02932	6.6	IC50	ChEMBL